Patents Assigned to ONCOIMMUNE INC.
  • USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
    Publication number: 20120264697
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia- Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Application
    Filed: June 25, 2010
    Publication date: October 18, 2012
    Applicant: ONCOIMMUNE INC.
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng